Location History:
- New York, NY (US) (2001 - 2012)
- Tenafly, NJ (US) (2007 - 2016)
Company Filing History:
Years Active: 2001-2016
Title: Innovations and Contributions of Inventor Shi Du Yan
Introduction
Shi Du Yan is a prominent inventor based in New York, NY, known for his significant contributions to medical research and innovation. With a total of 13 patents to his name, he has made remarkable strides in the fields of neurology and cellular biology. His work focuses on developing therapeutic methods for treating complex diseases, including multiple sclerosis and Alzheimer's disease.
Latest Patents
One of Shi Du Yan's latest patents involves methods for treating and preventing multiple sclerosis. His research has identified LRG-47, also known as p47 GTPase, as a central player in the pathogenesis of multiple sclerosis. The invention highlights the potential of anti-LRG-47 antibodies and siRNA to inhibit LRG-47 activity, thereby reducing the pathology and symptoms associated with the disease. Additionally, he has developed compositions aimed at inhibiting the interaction between ABAD and Aβ protein, which can be utilized in treating Alzheimer's disease. This invention also addresses the preservation of cell viability by preventing harmful cellular processes.
Career Highlights
Shi Du Yan is affiliated with Columbia University, where he conducts his research and develops innovative solutions to pressing medical challenges. His work has garnered attention for its potential impact on the treatment of autoimmune diseases and neurodegenerative disorders.
Collaborations
Throughout his career, Shi Du Yan has collaborated with esteemed colleagues, including David M Stern and Ann Marie Schmidt. These partnerships have further enriched his research and contributed to the advancement of medical science.
Conclusion
In summary, Shi Du Yan is a distinguished inventor whose work has significantly advanced the understanding and treatment of multiple sclerosis and Alzheimer's disease. His innovative patents and collaborations continue to pave the way for future breakthroughs in medical research.